[
  {
    "title": "东方生物(688298.SH)：第三季度净利降40.98%至3.099亿元",
    "href": "http://stock.jrj.com.cn/2022/10/30230837097961.shtml",
    "datetime": "2022-10-30 23:08:27",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：3项产品取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/09/02154236967856.shtml",
    "datetime": "2022-09-02 15:42:42",
    "code": "688298"
  },
  {
    "title": "A股异动 | 东方生物跌超11% 中期增收不增利 新冠检测产品售价大幅度下调",
    "href": "http://stock.jrj.com.cn/2022/08/30132736952113.shtml",
    "datetime": "2022-08-30 13:27:45",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)半年度净利润27.42亿元、同比下降19.23%",
    "href": "http://stock.jrj.com.cn/2022/08/29180936948105.shtml",
    "datetime": "2022-08-29 18:09:43",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：2021年度权益分派10转4派61.8元 股权登记日为6月15日",
    "href": "http://stock.jrj.com.cn/2022/06/09203636717178.shtml",
    "datetime": "2022-06-09 20:36:03",
    "code": "688298"
  },
  {
    "title": "东方生物：猴痘病毒DNA快速检测试剂等6款产品获欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2022/05/26170836681447.shtml",
    "datetime": "2022-05-26 17:08:43",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：6项产品取得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2022/05/26170136681465.shtml",
    "datetime": "2022-05-26 17:01:59",
    "code": "688298"
  },
  {
    "title": "东方生物2022年第一季度净利20.67亿同比增长74.2% 新冠抗原检测试剂销售收入增加",
    "href": "http://stock.jrj.com.cn/2022/05/03191136546526.shtml",
    "datetime": "2022-05-03 19:11:45",
    "code": "688298"
  },
  {
    "title": "东方生物2021年净利49.2亿同比增长193.33% 董事长方剑秋薪酬109.84万",
    "href": "http://stock.jrj.com.cn/2022/05/02173236533029.shtml",
    "datetime": "2022-05-02 17:32:43",
    "code": "688298"
  },
  {
    "title": "东方生物披露2021年年报 实现营收101.69亿元",
    "href": "http://stock.jrj.com.cn/2022/04/28085036490301.shtml",
    "datetime": "2022-04-28 08:50:53",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)2021年度净利润升193.33%至49.2亿元 拟10转4派61.8元",
    "href": "http://stock.jrj.com.cn/2022/04/27201536485973.shtml",
    "datetime": "2022-04-27 20:15:25",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)一季度净利润20.67亿元 同比增长74.20%",
    "href": "http://stock.jrj.com.cn/2022/04/27201236485976.shtml",
    "datetime": "2022-04-27 20:12:01",
    "code": "688298"
  },
  {
    "title": "东方生物3名股东减持285.25万股 套现合计5.39亿 2021年公司净利47.77亿",
    "href": "http://stock.jrj.com.cn/2022/04/11225236309441.shtml",
    "datetime": "2022-04-11 22:52:03",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：减持期届满 上海祥禾及其一致行动人共减持2.38%股份",
    "href": "http://stock.jrj.com.cn/2022/04/11174736305377.shtml",
    "datetime": "2022-04-11 17:47:58",
    "code": "688298"
  },
  {
    "title": "港股异动 | 东方生物涨5% 新冠病毒抗原自测试剂获加拿大临时授权指定供应",
    "href": "http://stock.jrj.com.cn/2022/04/06104836261402.shtml",
    "datetime": "2022-04-06 10:48:15",
    "code": "688298"
  },
  {
    "title": "东方生物：新型冠状病毒抗原自测试剂获得加拿大IO临时授权指定供应",
    "href": "http://stock.jrj.com.cn/2022/04/06101436261194.shtml",
    "datetime": "2022-04-06 10:14:29",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：新型冠状病毒抗原自测试剂获得加拿大IO临时授权指定供应",
    "href": "http://stock.jrj.com.cn/2022/04/05154136257782.shtml",
    "datetime": "2022-04-05 15:41:26",
    "code": "688298"
  },
  {
    "title": "东方生物聘任俞锦洪、章叶平、范幽雅为公司副总经理 2021年公司净利47.77亿",
    "href": "http://stock.jrj.com.cn/2022/03/21193034857118.shtml",
    "datetime": "2022-03-21 19:30:49",
    "code": "688298"
  },
  {
    "title": "东方生物：新冠病毒抗原检测试剂新增日本PMDA销售许可、沙特MDMA认证",
    "href": "http://stock.jrj.com.cn/2022/03/18171934845777.shtml",
    "datetime": "2022-03-18 17:19:22",
    "code": "688298"
  },
  {
    "title": "东方生物：新冠病毒抗原检测试剂新增日本PMDA销售许可、沙特MDMA认证",
    "href": "http://stock.jrj.com.cn/2022/03/18171534845761.shtml",
    "datetime": "2022-03-18 17:15:01",
    "code": "688298"
  },
  {
    "title": "东方生物：新型冠状病毒抗原检测试剂盒取得国内医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/03/16172234834759.shtml",
    "datetime": "2022-03-16 17:22:42",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：新型冠状病毒抗原检测试剂盒取得国内医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/03/16171134834705.shtml",
    "datetime": "2022-03-16 17:11:04",
    "code": "688298"
  },
  {
    "title": "四机构买入东方生物",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/14075934821669.shtml",
    "datetime": "2022-03-14 07:59:20",
    "code": "688298"
  },
  {
    "title": "东方生物2021年净利47.77亿同比增长184.8% 欧洲市场销售业绩大幅度增长",
    "href": "http://stock.jrj.com.cn/2022/02/25183034465422.shtml",
    "datetime": "2022-02-25 18:30:30",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：150万股战略配售限售股将解禁",
    "href": "http://stock.jrj.com.cn/2022/01/20181134179340.shtml",
    "datetime": "2022-01-20 18:11:29",
    "code": "688298"
  },
  {
    "title": "东方生物股价涨疯了！但预期的业绩增长能否出现仍不确定",
    "href": "http://stock.jrj.com.cn/2022/01/17134034164574.shtml",
    "datetime": "2022-01-17 13:40:00",
    "code": "688298"
  },
  {
    "title": "东方生物股价涨疯了！但预期的业绩增长能否出现仍不确定",
    "href": "http://stock.jrj.com.cn/2022/01/17134034213007.shtml",
    "datetime": "2022-01-17 13:40:00",
    "code": "688298"
  },
  {
    "title": "东方生物2021年预计净利47.2亿-51.2亿同比增加181%-205% 欧洲市场销售业绩大幅增长",
    "href": "http://stock.jrj.com.cn/2022/01/14220034159414.shtml",
    "datetime": "2022-01-14 22:00:04",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：美国市场新冠抗原自测试剂主要取决于西门子医疗的销售能力",
    "href": "http://stock.jrj.com.cn/2022/01/14190334158772.shtml",
    "datetime": "2022-01-14 19:03:26",
    "code": "688298"
  },
  {
    "title": "东方生物：2021年净利同比预增181%-205%",
    "href": "http://stock.jrj.com.cn/2022/01/14182534158590.shtml",
    "datetime": "2022-01-14 18:25:45",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)2021年度预盈47.2亿-51.2亿元 同比增长181.45%-205.31%",
    "href": "http://stock.jrj.com.cn/2022/01/14181234158560.shtml",
    "datetime": "2022-01-14 18:12:52",
    "code": "688298"
  },
  {
    "title": "新冠检测板块进一步拉升：安旭生物、美康生物、东方生物午后封板",
    "href": "http://stock.jrj.com.cn/2022/01/14135734157387.shtml",
    "datetime": "2022-01-14 13:57:32",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)突破300元创历史新高 受益海外检测试剂价格暴涨",
    "href": "http://stock.jrj.com.cn/2022/01/10155034141296.shtml",
    "datetime": "2022-01-10 15:50:19",
    "code": "688298"
  },
  {
    "title": "九安医疗、东方生物新冠检测试剂出口获商务部批准",
    "href": "http://stock.jrj.com.cn/2021/12/31143534092725.shtml",
    "datetime": "2021-12-31 14:35:02",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：新型冠状病毒抗原自测试剂获得美国FDA EUA授权指定供应",
    "href": "http://stock.jrj.com.cn/2021/12/30152434086699.shtml",
    "datetime": "2021-12-30 15:24:28",
    "code": "688298"
  },
  {
    "title": "东方生物大幅高开18.69%",
    "href": "http://stock.jrj.com.cn/2021/12/30092934085436.shtml",
    "datetime": "2021-12-30 09:29:59",
    "code": "688298"
  },
  {
    "title": "A股异动丨东方生物大幅高开18.69% 拟投资6亿元实施东方基因生物芯片产研基地项目",
    "href": "http://stock.jrj.com.cn/2021/12/30092734085434.shtml",
    "datetime": "2021-12-30 09:27:51",
    "code": "688298"
  },
  {
    "title": "东方生物签署《东方基因生物芯片产研基地项目投资协议》 投资总额约6亿",
    "href": "http://stock.jrj.com.cn/2021/12/29223234083242.shtml",
    "datetime": "2021-12-29 22:32:56",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：拟投资6亿元实施东方基因生物芯片产研基地项目",
    "href": "http://stock.jrj.com.cn/2021/12/29173634081941.shtml",
    "datetime": "2021-12-29 17:36:38",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：减持期过半 上海祥禾及其一致行动人已减持1.67%股份",
    "href": "http://stock.jrj.com.cn/2021/12/14161334014550.shtml",
    "datetime": "2021-12-14 16:13:11",
    "code": "688298"
  },
  {
    "title": "东方生物拟投资500万美元在英国苏格兰设立全资子公司爱可生物",
    "href": "http://stock.jrj.com.cn/2021/12/07191033981139.shtml",
    "datetime": "2021-12-07 19:10:54",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：拟在英国苏格兰投资500万美元设爱可生物",
    "href": "http://stock.jrj.com.cn/2021/12/07165733980438.shtml",
    "datetime": "2021-12-07 16:57:01",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)第三季度净利润5.25亿元 同比增长273.65%",
    "href": "http://stock.jrj.com.cn/2021/10/29220433780305.shtml",
    "datetime": "2021-10-29 22:04:07",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：上海祥禾及其一致行动人减持股份达1.00%",
    "href": "http://stock.jrj.com.cn/2021/10/18160733710995.shtml",
    "datetime": "2021-10-18 16:07:54",
    "code": "688298"
  },
  {
    "title": "东方生物2名股东合计减持384.76万股 套现合计7.19亿 上半年公司净利33.94亿",
    "href": "http://stock.jrj.com.cn/2021/09/22200833500132.shtml",
    "datetime": "2021-09-22 20:08:07",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：减持期届满 浙江永石及其一致行动人已减持3.21%股份",
    "href": "http://stock.jrj.com.cn/2021/09/22160033499003.shtml",
    "datetime": "2021-09-22 16:00:24",
    "code": "688298"
  },
  {
    "title": "A股异动丨东方生物(688298.SH)跌近6% 上海祥禾等股东拟减持不超6.2%",
    "href": "http://stock.jrj.com.cn/2021/09/08095833402545.shtml",
    "datetime": "2021-09-08 09:58:43",
    "code": "688298"
  },
  {
    "title": "东方生物股东及其一致行动人合计拟减持不超744.49万股公司股份 上半年公司净利33.94亿",
    "href": "http://stock.jrj.com.cn/2021/09/07193833399763.shtml",
    "datetime": "2021-09-07 19:38:27",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：上海祥禾、上海涌创、连云港涌拟减持合计不超6.2%股份",
    "href": "http://stock.jrj.com.cn/2021/09/07165533398870.shtml",
    "datetime": "2021-09-07 16:55:37",
    "code": "688298"
  },
  {
    "title": "东方生物3名股东合计减持999.98万股 套现合计17.05亿 上半年公司净利33.94亿",
    "href": "http://stock.jrj.com.cn/2021/09/06195133394168.shtml",
    "datetime": "2021-09-06 19:51:28",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：上海祥禾及其一致行动人完成减持8.33%股份",
    "href": "http://stock.jrj.com.cn/2021/09/06172433392700.shtml",
    "datetime": "2021-09-06 17:24:01",
    "code": "688298"
  },
  {
    "title": "东方生物2021年半年度净利33.94亿元 同比净利增加547.82%",
    "href": "http://stock.jrj.com.cn/2021/08/30115233350976.shtml",
    "datetime": "2021-08-30 11:52:34",
    "code": "688298"
  },
  {
    "title": "东方生物上半年业绩增五倍 研发没“掉队” 有望突破海外技术垄断",
    "href": "http://stock.jrj.com.cn/2021/08/30112833351256.shtml",
    "datetime": "2021-08-30 11:28:00",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)半年度净利润33.94亿元 同比增长547.82%",
    "href": "http://stock.jrj.com.cn/2021/08/29181833340961.shtml",
    "datetime": "2021-08-29 18:18:09",
    "code": "688298"
  },
  {
    "title": "东方生物：上半年净利同比增长548% 新冠检测试剂销售业绩再创新高",
    "href": "http://stock.jrj.com.cn/2021/08/29175233340887.shtml",
    "datetime": "2021-08-29 17:52:48",
    "code": "688298"
  },
  {
    "title": "东方生物：上海祥禾及其一致行动人已减持1%的股份",
    "href": "http://stock.jrj.com.cn/2021/08/18162033273913.shtml",
    "datetime": "2021-08-18 16:20:44",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：上海祥禾及其一致行动人已减持1%的股份",
    "href": "http://stock.jrj.com.cn/2021/08/18160733273848.shtml",
    "datetime": "2021-08-18 16:07:31",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：上海祥禾及其一致行动人已减持1%的股份",
    "href": "http://stock.jrj.com.cn/2021/08/06171533213321.shtml",
    "datetime": "2021-08-06 17:15:49",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：浙江永石及其一致行动人的持股比例从7.61%减至4.9998%",
    "href": "http://stock.jrj.com.cn/2021/08/05220033209282.shtml",
    "datetime": "2021-08-05 22:00:40",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：新型冠状病毒(抗原)自测试剂获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2021/08/03163533195243.shtml",
    "datetime": "2021-08-03 16:35:00",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：上海祥禾方面3月2日以来累计减持6.14%股份",
    "href": "http://stock.jrj.com.cn/2021/07/20162233124518.shtml",
    "datetime": "2021-07-20 16:22:25",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)2020年度权益分派10派42元 股权登记日为7月8日",
    "href": "http://stock.jrj.com.cn/2021/07/02170633034126.shtml",
    "datetime": "2021-07-02 17:06:03",
    "code": "688298"
  },
  {
    "title": "东方生物2021年上半年预计净利29.8亿-35.3亿 新冠检测试剂销售取得突破",
    "href": "http://stock.jrj.com.cn/2021/06/29213033017680.shtml",
    "datetime": "2021-06-29 21:30:12",
    "code": "688298"
  },
  {
    "title": "【公告抢先看】晚间公告：本钢板材上半年预盈约22亿元、东方生物上半年净利同比预增469%-574%",
    "href": "http://stock.jrj.com.cn/2021/06/29185533017052.shtml",
    "datetime": "2021-06-29 18:55:28",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：上半年净利预增468.76%到573.73%左右",
    "href": "http://stock.jrj.com.cn/2021/06/29182833016917.shtml",
    "datetime": "2021-06-29 18:28:37",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：上海祥禾方面减持股份比例达到1%",
    "href": "http://stock.jrj.com.cn/2021/06/25154532996490.shtml",
    "datetime": "2021-06-25 15:45:06",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：浙江永石及其一致行动人减持1%股份",
    "href": "http://stock.jrj.com.cn/2021/06/18155532954744.shtml",
    "datetime": "2021-06-18 15:55:25",
    "code": "688298"
  },
  {
    "title": "东方生物：新冠病毒抗原自测试剂获得英国EUA特殊使用授权",
    "href": "http://stock.jrj.com.cn/2021/06/10102932904049.shtml",
    "datetime": "2021-06-10 10:29:15",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：新冠抗原自测试剂获得英国EUA特殊使用授权",
    "href": "http://stock.jrj.com.cn/2021/06/09171532900259.shtml",
    "datetime": "2021-06-09 17:15:15",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：浙江永石、上海永石减持期过半 合计减持1.47%股份",
    "href": "http://stock.jrj.com.cn/2021/06/07171232887367.shtml",
    "datetime": "2021-06-07 17:12:09",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：浙江永石及上海永石合计减持比例达1%",
    "href": "http://stock.jrj.com.cn/2021/05/24160832810747.shtml",
    "datetime": "2021-05-24 16:08:20",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)股东上海祥禾及一致行动人累计减持361.6万股 减持计划尚未实施完毕",
    "href": "http://stock.jrj.com.cn/2021/05/16160132761345.shtml",
    "datetime": "2021-05-16 16:01:51",
    "code": "688298"
  },
  {
    "title": "东方生物：2020年公司收入及利润主要来自于 POCT 快速诊断试剂",
    "href": "http://stock.jrj.com.cn/2021/05/10132932728526.shtml",
    "datetime": "2021-05-10 13:29:19",
    "code": "688298"
  },
  {
    "title": "东方生物：2021年公司将加速推动液态生物芯片平台的产业化、市场化进程",
    "href": "http://stock.jrj.com.cn/2021/05/10132732728506.shtml",
    "datetime": "2021-05-10 13:27:57",
    "code": "688298"
  },
  {
    "title": "东方生物：除了产能扩张、投产布局等经营性投资外 公司暂时没有其他重大投资计划",
    "href": "http://stock.jrj.com.cn/2021/05/10132532728494.shtml",
    "datetime": "2021-05-10 13:25:35",
    "code": "688298"
  },
  {
    "title": "东方生物：公司将始终坚持“客户导向、持续创新、敢打善拼、共同成长”的核心价值观",
    "href": "http://stock.jrj.com.cn/2021/05/10132032728463.shtml",
    "datetime": "2021-05-10 13:20:02",
    "code": "688298"
  },
  {
    "title": "东方生物：公司原有业务产能被新冠检测试剂严重挤兑",
    "href": "http://stock.jrj.com.cn/2021/05/10131732728430.shtml",
    "datetime": "2021-05-10 13:17:30",
    "code": "688298"
  },
  {
    "title": "东方生物：公司目前仍以海外销售为主 2020年度海外市场销售占比约95%",
    "href": "http://stock.jrj.com.cn/2021/05/10131632728429.shtml",
    "datetime": "2021-05-10 13:16:33",
    "code": "688298"
  },
  {
    "title": "东方生物：2020年度公司POCT快速诊断试剂总产能4.5亿人份",
    "href": "http://stock.jrj.com.cn/2021/05/10131432728418.shtml",
    "datetime": "2021-05-10 13:14:48",
    "code": "688298"
  },
  {
    "title": "东方生物：公司于近日取得新型冠状病毒抗原自测试剂、新型冠状病毒抗原检测试剂（唾液）欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2021/05/10131332728411.shtml",
    "datetime": "2021-05-10 13:13:05",
    "code": "688298"
  },
  {
    "title": "仿制药、新冠检测概念再度走强 东方生物海特生物等大涨",
    "href": "http://stock.jrj.com.cn/2021/04/30101832485243.shtml",
    "datetime": "2021-04-30 10:18:00",
    "code": "688298"
  },
  {
    "title": "东方生物2020年净利 增长1942.94% 董事长方效良薪酬83.17万",
    "href": "http://stock.jrj.com.cn/2021/04/29142132479648.shtml",
    "datetime": "2021-04-29 14:21:14",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)一季度净利润升2601.42%至11.86亿元",
    "href": "http://stock.jrj.com.cn/2021/04/28193732473385.shtml",
    "datetime": "2021-04-28 19:37:59",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)2020年度净利润升1942.94%至16.77亿元 拟10派42元",
    "href": "http://stock.jrj.com.cn/2021/04/28193532473374.shtml",
    "datetime": "2021-04-28 19:35:39",
    "code": "688298"
  },
  {
    "title": "东方生物：一季度净利润同比增长2601% 年报拟10派42元",
    "href": "http://stock.jrj.com.cn/2021/04/28183732473074.shtml",
    "datetime": "2021-04-28 18:37:16",
    "code": "688298"
  },
  {
    "title": "东方生物：上海祥禾等减持超过1% 不会导致实控人发生变化",
    "href": "http://stock.jrj.com.cn/2021/04/19174832403007.shtml",
    "datetime": "2021-04-19 17:48:31",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：上海祥禾及其一致行动人已减持1%的股份",
    "href": "http://stock.jrj.com.cn/2021/04/19171232402745.shtml",
    "datetime": "2021-04-19 17:12:54",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：上海祥禾及其一致行动人减持1%股份",
    "href": "http://stock.jrj.com.cn/2021/04/02221332272682.shtml",
    "datetime": "2021-04-02 22:13:43",
    "code": "688298"
  },
  {
    "title": "东方生物：以9056.81万元成交价网拍竞价获得艾玛公司建筑物等资产",
    "href": "http://stock.jrj.com.cn/2021/03/19175732165086.shtml",
    "datetime": "2021-03-19 17:57:34",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：拟使用额度不超2亿元部分暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/03/19165732164645.shtml",
    "datetime": "2021-03-19 16:57:28",
    "code": "688298"
  },
  {
    "title": "东方生物：近期6款新型冠状病毒检测产品获欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2021/03/11102732108008.shtml",
    "datetime": "2021-03-11 10:27:18",
    "code": "688298"
  },
  {
    "title": "东方生物：上海祥禾及其一致行动人合计减持超过1%",
    "href": "http://stock.jrj.com.cn/2021/03/11090732107532.shtml",
    "datetime": "2021-03-11 09:07:35",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：上海祥禾及其一致行动人减持1%股份",
    "href": "http://stock.jrj.com.cn/2021/03/10175632104538.shtml",
    "datetime": "2021-03-10 17:56:32",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：6款新型冠状病毒检测产品获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2021/03/10175532104534.shtml",
    "datetime": "2021-03-10 17:55:03",
    "code": "688298"
  },
  {
    "title": "因资金需要，东方生物股东浙江永石、上海永石拟减持不超432万股",
    "href": "http://stock.jrj.com.cn/2021/03/02090432055301.shtml",
    "datetime": "2021-03-02 09:04:09",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：浙江永石、上海永石拟合计减持不超3.60%股份",
    "href": "http://stock.jrj.com.cn/2021/03/01161932050594.shtml",
    "datetime": "2021-03-01 16:19:47",
    "code": "688298"
  },
  {
    "title": "A股异动丨东方生物(688298.SH)涨5.44% 2020年度净利润暴增1956.37%",
    "href": "http://stock.jrj.com.cn/2021/03/01093832048106.shtml",
    "datetime": "2021-03-01 09:38:13",
    "code": "688298"
  },
  {
    "title": "东方生物2020年度净利16.88亿增长1956.37% 新冠抗原快速检测试纸取得销售业绩突破",
    "href": "http://stock.jrj.com.cn/2021/02/27114132037931.shtml",
    "datetime": "2021-02-27 11:41:00",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)业绩快报：2020年度净利润升1956.37%至16.88亿元",
    "href": "http://stock.jrj.com.cn/2021/02/26171932033706.shtml",
    "datetime": "2021-02-26 17:19:41",
    "code": "688298"
  },
  {
    "title": "东方生物业绩快报：2020年净利润16.88亿元 同比增1956%",
    "href": "http://stock.jrj.com.cn/2021/02/26170332033601.shtml",
    "datetime": "2021-02-26 17:03:45",
    "code": "688298"
  },
  {
    "title": "东方生物：股东上海祥禾、上海涌创、连云港涌诚拟合计减持不超1080万股",
    "href": "http://stock.jrj.com.cn/2021/02/07090831859954.shtml",
    "datetime": "2021-02-07 09:08:51",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)：上海祥禾及其一致行动人拟减持不超9%的股份",
    "href": "http://stock.jrj.com.cn/2021/02/05180631855562.shtml",
    "datetime": "2021-02-05 18:06:31",
    "code": "688298"
  },
  {
    "title": "东方生物董事叶苏辞职",
    "href": "http://stock.jrj.com.cn/2021/01/28204631802751.shtml",
    "datetime": "2021-01-28 20:46:00",
    "code": "688298"
  },
  {
    "title": "新冠检测产品市场化推动，东方生物2020年归母净利润同比预增近18倍",
    "href": "http://stock.jrj.com.cn/2021/01/06102131639865.shtml",
    "datetime": "2021-01-06 10:21:17",
    "code": "688298"
  },
  {
    "title": "东方生物2020年预计净利15.56亿 整体经营业绩大幅度增长",
    "href": "http://stock.jrj.com.cn/2021/01/05211931636651.shtml",
    "datetime": "2021-01-05 21:19:45",
    "code": "688298"
  },
  {
    "title": "东方生物净利预增近18倍",
    "href": "http://stock.jrj.com.cn/2021/01/05205631636553.shtml",
    "datetime": "2021-01-05 20:56:00",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)2020年度净利润预增1795.1%左右",
    "href": "http://stock.jrj.com.cn/2021/01/05184531635780.shtml",
    "datetime": "2021-01-05 18:45:22",
    "code": "688298"
  },
  {
    "title": "东方生物(688298.SH)取得3项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2020/12/04171331408891.shtml",
    "datetime": "2020-12-04 17:13:46",
    "code": "688298"
  },
  {
    "title": "海外新冠抗原试纸供不应求 东方生物产品订单充足",
    "href": "http://stock.jrj.com.cn/2020/11/24021831334477.shtml",
    "datetime": "2020-11-24 02:18:01",
    "code": "688298"
  },
  {
    "title": "东方生物：公司已成为英国卫生部采购新冠抗原检测试剂的重要供应商之一",
    "href": "http://stock.jrj.com.cn/2020/11/19114131314787.shtml",
    "datetime": "2020-11-19 11:41:42",
    "code": "688298"
  },
  {
    "title": "东方生物：公司新冠检测产品开发速度快、迭代更新能力强",
    "href": "http://stock.jrj.com.cn/2020/11/19084131313463.shtml",
    "datetime": "2020-11-19 08:41:46",
    "code": "688298"
  },
  {
    "title": "东方生物：公司上半年以新冠抗体检测产品为主 第三季度开始重点推动新冠抗原检测试剂的市场化工作",
    "href": "http://stock.jrj.com.cn/2020/11/19084131313458.shtml",
    "datetime": "2020-11-19 08:41:03",
    "code": "688298"
  },
  {
    "title": "东方生物：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/28001031145374.shtml",
    "datetime": "2020-10-28 00:10:21",
    "code": "688298"
  },
  {
    "title": "东方生物前三季度净利6.64亿增长1038.69% 新冠检测产品收入大幅度增加",
    "href": "http://stock.jrj.com.cn/2020/10/27192931143796.shtml",
    "datetime": "2020-10-27 19:29:36",
    "code": "688298"
  },
  {
    "title": "A股异动丨东方生物(688298.SH)涨超6% 预计到三季度末的净利同比增长50%以上",
    "href": "http://stock.jrj.com.cn/2020/09/22131830809402.shtml",
    "datetime": "2020-09-22 13:18:29",
    "code": "688298"
  },
  {
    "title": "东方生物上半年净利同比增长1477.45%",
    "href": "http://stock.jrj.com.cn/2020/08/07225630452463.shtml",
    "datetime": "2020-08-07 22:56:06",
    "code": "688298"
  },
  {
    "title": "东方生物中报净利大增14倍",
    "href": "http://stock.jrj.com.cn/2020/08/07220430452755.shtml",
    "datetime": "2020-08-07 22:04:00",
    "code": "688298"
  },
  {
    "title": "东方生物中报净利大增14倍",
    "href": "http://stock.jrj.com.cn/2020/08/07220430502449.shtml",
    "datetime": "2020-08-07 22:04:00",
    "code": "688298"
  },
  {
    "title": "东方生物上半年净利润同比增逾14倍",
    "href": "http://stock.jrj.com.cn/2020/08/07184830451461.shtml",
    "datetime": "2020-08-07 18:48:12",
    "code": "688298"
  },
  {
    "title": "东方生物2020年上半年净利5.24亿增长1477.45% 新增新冠病毒检测试剂销售收入",
    "href": "http://stock.jrj.com.cn/2020/08/07182530451343.shtml",
    "datetime": "2020-08-07 18:25:15",
    "code": "688298"
  },
  {
    "title": "东方生物2020年上半年预计实现净利4.63亿元 同比增加1294.1%左右",
    "href": "http://stock.jrj.com.cn/2020/07/10213330207779.shtml",
    "datetime": "2020-07-10 21:33:35",
    "code": "688298"
  },
  {
    "title": "东方生物半年报净利同比预增1294%",
    "href": "http://stock.jrj.com.cn/2020/07/10194830207197.shtml",
    "datetime": "2020-07-10 19:48:01",
    "code": "688298"
  },
  {
    "title": "快讯：东方生物急速拉升7.41% 主力资金净流出69.97万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/07101230163682.shtml",
    "datetime": "2020-07-07 10:12:00",
    "code": "688298"
  },
  {
    "title": "快讯：东方生物急速拉升5.03% 主力资金净流入1190.31万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/02095030119213.shtml",
    "datetime": "2020-07-02 09:50:02",
    "code": "688298"
  },
  {
    "title": "快讯：东方生物急速拉升5.03% 主力资金净流入1546.54万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/02094830119176.shtml",
    "datetime": "2020-07-02 09:48:11",
    "code": "688298"
  },
  {
    "title": "东方生物：2020年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/06/05232029855940.shtml",
    "datetime": "2020-06-05 23:20:00",
    "code": "688298"
  },
  {
    "title": "东方生物：2019年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2020/06/04004029839809.shtml",
    "datetime": "2020-06-04 00:40:28",
    "code": "688298"
  },
  {
    "title": "东方生物新冠肺炎检测产品获得美国FDA紧急使用授权",
    "href": "http://stock.jrj.com.cn/2020/05/31163629804413.shtml",
    "datetime": "2020-05-31 16:36:22",
    "code": "688298"
  },
  {
    "title": "东方生物：全资子公司新冠检测产品获得美国FDA紧急使用授权",
    "href": "http://stock.jrj.com.cn/kcb/2020/05/31142729804168.shtml",
    "datetime": "2020-05-31 14:27:33",
    "code": "688298"
  },
  {
    "title": "两大主业有优势 A股“新生”东方生物直面国外垄断巨头",
    "href": "http://stock.jrj.com.cn/2020/05/25081829757603.shtml",
    "datetime": "2020-05-25 08:18:00",
    "code": "688298"
  },
  {
    "title": "东方生物新冠病毒核酸检测试剂盒取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2020/05/22203729742371.shtml",
    "datetime": "2020-05-22 20:37:50",
    "code": "688298"
  },
  {
    "title": "东方生物：关于召开2020年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/05/21074029727881.shtml",
    "datetime": "2020-05-21 07:40:02",
    "code": "688298"
  },
  {
    "title": "东方生物：2019年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/05/21074029727878.shtml",
    "datetime": "2020-05-21 07:40:02",
    "code": "688298"
  },
  {
    "title": "东方生物：第一届董事会第十七次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/05/21074029727879.shtml",
    "datetime": "2020-05-21 07:40:02",
    "code": "688298"
  },
  {
    "title": "东方生物总经理方效良辞职 聘任方剑秋为总经理",
    "href": "http://stock.jrj.com.cn/2020/05/03173929502042.shtml",
    "datetime": "2020-05-03 17:39:54",
    "code": "688298"
  },
  {
    "title": "东方生物2020年第一季度盈利4391.6万增长262.52% 新冠检测试剂产品销售收入增加",
    "href": "http://stock.jrj.com.cn/2020/05/01143029440100.shtml",
    "datetime": "2020-05-01 14:30:32",
    "code": "688298"
  },
  {
    "title": "东方生物2019年盈利8211万增长26% 加大国内外市场开拓广度和深度",
    "href": "http://stock.jrj.com.cn/2020/04/28185129406690.shtml",
    "datetime": "2020-04-28 18:51:24",
    "code": "688298"
  },
  {
    "title": "东方生物：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/28155029405115.shtml",
    "datetime": "2020-04-28 15:50:18",
    "code": "688298"
  },
  {
    "title": "东方生物：2020年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/28155029405116.shtml",
    "datetime": "2020-04-28 15:50:18",
    "code": "688298"
  },
  {
    "title": "东方生物：第一届董事会第十六次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/04/28155029405113.shtml",
    "datetime": "2020-04-28 15:50:18",
    "code": "688298"
  },
  {
    "title": "东方生物：关于召开2019年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/04/28155029405114.shtml",
    "datetime": "2020-04-28 15:50:18",
    "code": "688298"
  },
  {
    "title": "东方生物：2019年净利同比增长25.60％ 拟10派2.10元",
    "href": "http://stock.jrj.com.cn/2020/04/27185629397401.shtml",
    "datetime": "2020-04-27 18:56:04",
    "code": "688298"
  },
  {
    "title": "东方生物聘任章叶平为公司董事会秘书",
    "href": "http://stock.jrj.com.cn/2020/03/24192129210003.shtml",
    "datetime": "2020-03-24 19:21:00",
    "code": "688298"
  },
  {
    "title": "东方生物聘任章叶平为公司董事会秘书",
    "href": "http://stock.jrj.com.cn/2020/03/24192129096587.shtml",
    "datetime": "2020-03-24 19:21:00",
    "code": "688298"
  },
  {
    "title": "东方生物聘任章叶平为董事会秘书",
    "href": "http://stock.jrj.com.cn/2020/03/24183729096316.shtml",
    "datetime": "2020-03-24 18:37:44",
    "code": "688298"
  },
  {
    "title": "东方生物蹭抗疫情热点 公司及董秘王晓波遭通报批评",
    "href": "http://stock.jrj.com.cn/2020/03/09111228977988.shtml",
    "datetime": "2020-03-09 11:12:00",
    "code": "688298"
  },
  {
    "title": "新冠病毒测试剂公告闹乌龙 东方生物遭浙江证监局警示",
    "href": "http://stock.jrj.com.cn/2020/03/08215828974451.shtml",
    "datetime": "2020-03-08 21:58:25",
    "code": "688298"
  },
  {
    "title": "东方生物披露“新冠病毒”检测产品信息不准确 上交所对公司及其时任董秘予以通报批评",
    "href": "http://stock.jrj.com.cn/2020/03/08215728974480.shtml",
    "datetime": "2020-03-08 21:57:00",
    "code": "688298"
  },
  {
    "title": "东方生物：公司及高管收到浙江证监局警示函",
    "href": "http://stock.jrj.com.cn/2020/03/08191028974133.shtml",
    "datetime": "2020-03-08 19:10:00",
    "code": "688298"
  },
  {
    "title": "东方生物2019年净利8219万增长26% 研发投入持续进行",
    "href": "http://stock.jrj.com.cn/2020/02/27224828909379.shtml",
    "datetime": "2020-02-27 22:48:41",
    "code": "688298"
  },
  {
    "title": "东方生物：2019年净利8219万元 同比增长26%",
    "href": "http://stock.jrj.com.cn/2020/02/27214728909112.shtml",
    "datetime": "2020-02-27 21:47:06",
    "code": "688298"
  },
  {
    "title": "东方生物储备三款检测试剂助力海外战“疫",
    "href": "http://stock.jrj.com.cn/2020/02/27192428908344.shtml",
    "datetime": "2020-02-27 19:24:14",
    "code": "688298"
  },
  {
    "title": "587%涨幅曾创科创板记录 蹭热点的东方生物今遭问询",
    "href": "http://stock.jrj.com.cn/2020/02/26202528899410.shtml",
    "datetime": "2020-02-26 20:25:49",
    "code": "688298"
  },
  {
    "title": "东方生物：新冠病毒检测试剂在备案号获得前可视为已备案获得欧盟市场准入",
    "href": "http://stock.jrj.com.cn/2020/02/23183628876981.shtml",
    "datetime": "2020-02-23 18:36:00",
    "code": "688298"
  },
  {
    "title": "东方生物澄清：尚未取得欧盟给予的新冠病毒诊断系列产品的备案登记号",
    "href": "http://stock.jrj.com.cn/2020/02/23145228876634.shtml",
    "datetime": "2020-02-23 14:52:31",
    "code": "688298"
  },
  {
    "title": "东方生物：尚未取得欧盟给予的新冠病毒诊断系列产品的备案登记号",
    "href": "http://stock.jrj.com.cn/2020/02/23144228876623.shtml",
    "datetime": "2020-02-23 14:42:00",
    "code": "688298"
  },
  {
    "title": "东方生物澄清：公司尚未取得欧盟给予的新冠病毒诊断系列产品的备案登记号",
    "href": "http://stock.jrj.com.cn/kcb/2020/02/23143828876621.shtml",
    "datetime": "2020-02-23 14:38:19",
    "code": "688298"
  },
  {
    "title": "东方生物使用不超5亿元闲置资金进行理财规划",
    "href": "http://stock.jrj.com.cn/2020/02/18084028845935.shtml",
    "datetime": "2020-02-18 08:40:54",
    "code": "688298"
  },
  {
    "title": "大涨586.96%！东方生物紧急提示风险 医药板块还有50只个股涨停",
    "href": "http://stock.jrj.com.cn/hotstock/2020/02/06064328779229.shtml",
    "datetime": "2020-02-06 06:43:45",
    "code": "688298"
  },
  {
    "title": "上证指数重回2800点 医疗板块续演涨停潮",
    "href": "http://stock.jrj.com.cn/2020/02/06040028778963.shtml",
    "datetime": "2020-02-06 04:00:33",
    "code": "688298"
  },
  {
    "title": "东方生物：新型冠状病毒系列检测试剂盒产品不会对当期收入及利润产生",
    "href": "http://stock.jrj.com.cn/2020/02/05204928778140.shtml",
    "datetime": "2020-02-05 20:49:29",
    "code": "688298"
  },
  {
    "title": "东方生物：新型冠状病毒系列检测试剂盒产品不会对当期收入及利润产生影响",
    "href": "http://stock.jrj.com.cn/2020/02/05195428777903.shtml",
    "datetime": "2020-02-05 19:54:50",
    "code": "688298"
  },
  {
    "title": "东方生物上市首日涨近6倍：新型冠状病毒系列检测试剂盒产品不会对当期收入及利润产生",
    "href": "http://stock.jrj.com.cn/2020/02/05195428777915.shtml",
    "datetime": "2020-02-05 19:54:00",
    "code": "688298"
  },
  {
    "title": "东方生物上市 首日涨幅创科创板新高",
    "href": "http://stock.jrj.com.cn/2020/02/05165628776827.shtml",
    "datetime": "2020-02-05 16:56:19",
    "code": "688298"
  },
  {
    "title": "科创板新股东方生物上市首日暴涨585.2% 第二次临时停牌",
    "href": "http://stock.jrj.com.cn/2020/02/05143428775841.shtml",
    "datetime": "2020-02-05 14:34:18",
    "code": "688298"
  },
  {
    "title": "东方生物今日科创板挂牌 盘中大涨456%",
    "href": "http://stock.jrj.com.cn/2020/02/05143028775839.shtml",
    "datetime": "2020-02-05 14:30:01",
    "code": "688298"
  },
  {
    "title": "科创板新股东方生物上市首日暴涨456.7% 遭遇临时停牌",
    "href": "http://stock.jrj.com.cn/2020/02/05142528775810.shtml",
    "datetime": "2020-02-05 14:25:22",
    "code": "688298"
  },
  {
    "title": "东方生物今日上市 发行价格21.25元/股",
    "href": "http://stock.jrj.com.cn/ipo/2020/02/05082628773542.shtml",
    "datetime": "2020-02-05 08:26:29",
    "code": "688298"
  },
  {
    "title": "【兑奖啦】博杰股份网上申购中签号出炉 共34733个",
    "href": "http://stock.jrj.com.cn/ipo/2020/01/19183328701795.shtml",
    "datetime": "2020-01-19 18:33:08",
    "code": "688298"
  },
  {
    "title": "【兑奖啦】东方生物、公牛集团网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2020/01/19150828701316.shtml",
    "datetime": "2020-01-19 15:08:28",
    "code": "688298"
  },
  {
    "title": "柳药股份：柳药转债中签号出炉 共285496个",
    "href": "http://stock.jrj.com.cn/2020/01/19141528701212.shtml",
    "datetime": "2020-01-19 14:15:16",
    "code": "688298"
  },
  {
    "title": "东方生物网上发行最终中签率为0.041%",
    "href": "http://stock.jrj.com.cn/ipo/2020/01/17081428690468.shtml",
    "datetime": "2020-01-17 08:14:22",
    "code": "688298"
  },
  {
    "title": "东方生物IPO：网上中签率0.04127603%",
    "href": "http://stock.jrj.com.cn/2020/01/16211428688718.shtml",
    "datetime": "2020-01-16 21:14:24",
    "code": "688298"
  },
  {
    "title": "东方生物今日申购 顶格申购需配市值8.5万元",
    "href": "http://stock.jrj.com.cn/ipo/2020/01/16084928684528.shtml",
    "datetime": "2020-01-16 08:49:56",
    "code": "688298"
  },
  {
    "title": "新股提示：东方生物、公牛集团、博杰股份今日申购",
    "href": "http://stock.jrj.com.cn/2020/01/16072128684292.shtml",
    "datetime": "2020-01-16 07:21:00",
    "code": "688298"
  },
  {
    "title": "科创板新股东方生物1月16日申购宝典",
    "href": "http://stock.jrj.com.cn/kcb/2020/01/15140228680322.shtml",
    "datetime": "2020-01-15 14:02:30",
    "code": "688298"
  }
]